Lead Sponsor

Erbe Elektromedizin GmbH

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

•1. Female patient with primary invasive breast cancer (NST or NST with DCIS component, including endocrine pretreatment according to standard of care therapy at the study site)
•2. Solid tumor size ≥ 15 mm at screening, on sonography imaging
•3. Breast conserving surgery
•4. ≥ 18 years of age
•5. Ability to provide written informed consent

•1. Neoadjuvant chemotherapy
•2. Bilateral breast conserving surgery
•3. Invasive lobular carcinoma, DCIS, LCIS
•4. Suspicion of extensive DCIS component of NST tumor
•5. Diagnosis of recurrent breast cancer
•6. Previous radiotherapy
•7. Patient is pregnant or lactating
•8. Patient is wearing active implant (cardiac pacemaker, internal defibrillator, other active implant), passive implants (hip arthroplasties, tooth implants etc.) are allowed at the discretion of the principal investigator
•9. According to physicians' assessment, patient is not able to follow study protocol (e.g., due to cognitive disease) or is not able to understand the nature, objectives, benefits, implications, risks and inconveniences of the clinical investigation

Related studies

NCT07586215 · Breast Cancer Metastatic

NCT05831878 · Advanced Breast Cancer

NCT06525766 · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen-receptor-positive Breast Cancer, and more

NCT07368998 · Breast Cancer

NCT07578064 · Breast Cancer, Bone Marrow Suppression

Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection